TownSquare Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,023
Closed -$211K 1379
2025
Q1
$211K Sell
16,023
-1,810
-10% -$25K ﹤0.01% 1541
2024
Q4
$282K Sell
17,833
-182
-1% -$2.73K ﹤0.01% 1284
2024
Q3
$286K Buy
+18,015
New +$290K ﹤0.01% 1184
2021
Q1
Sell
-14,460
Closed -$206K 580
2020
Q4
$206K Sell
14,460
-350
-2% -$4.71K 0.01% 458
2020
Q3
$205K Buy
+14,810
New +$177K 0.01% 400
2020
Q1
Sell
-25,665
Closed -$209K 487
2019
Q4
$209K Buy
25,665
+485
+2% +$3.83K 0.02% 414
2019
Q3
$203K Buy
+25,180
New +$187K 0.02% 468

Other funds holding RDY

TownSquare Capital's RDY Position: Q2 2025 in Review

TownSquare Capital sold out of Dr. Reddy's Laboratories (RDY) in Q2 2025, closing a stake of 16,023 shares — an estimated $211K sold.

TownSquare Capital first reported a position in RDY in Q3 2019 and held it in 7 quarters. The position peaked at $286K in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q2 2025.

  • TownSquare Capital reported no remaining Dr. Reddy's Laboratories position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 16,023 Dr. Reddy's Laboratories shares in Q2 2025, an estimated $211K.
  • TownSquare Capital first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 7 quarters.
  • TownSquare Capital's Dr. Reddy's Laboratories position peaked at $286K in Q3 2024.
  • 243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.